Shareholders' Deficit (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|
Jan. 13, 2020 |
Dec. 12, 2019 |
Feb. 20, 2020 |
Feb. 18, 2020 |
Nov. 30, 2019 |
Oct. 31, 2019 |
Mar. 31, 2020 |
Mar. 31, 2019 |
Dec. 31, 2019 |
|
| Shareholders' Deficit (Textual) | |||||||||
| Preferred Stock par value | $ 0.10 | $ 0.10 | |||||||
| Net of fees | $ 500 | ||||||||
| Amortization of Debt Discount | 148,917 | $ 2,883 | |||||||
| Accrued interest | $ 12,220 | ||||||||
| Common shares issued for debt conversion, shares | 475,000 | ||||||||
| Stock-based compensation | $ 170,072 | 909,375 | |||||||
| Interest expense | 241,203 | 52,534 | |||||||
| Issuance of common shares for services, amount | 50,000 | ||||||||
| Stock-based professional fees | $ (15,000) | (49,646) | |||||||
| Non-vested shares | |||||||||
| Recognized compensation expense | $ 7,500 | ||||||||
| Total unrecognized compensation expense related to unvested common shares | $ 103,642 | ||||||||
| Weighted average period | 1 year | ||||||||
| Aggregate principal amount | $ 279,167 | $ 135,833 | |||||||
| Unrecognized compensation expense | 103,642 | ||||||||
| Exercise of stock options, value | |||||||||
| Recorded settlement expense | |||||||||
| Increase decrease in accounts payable | 31,113 | 124,527 | |||||||
| Increase decrease in accrued expenses | $ 29,609 | 9,592 | |||||||
| Stock option, description | The weighted average period over which stock-based compensation expense related to these options will be recognized is approximately 7 months. | ||||||||
| Accrued dividend payable | $ 2,219 | ||||||||
| Equity Option [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Recognized compensation expense | 191,308 | $ 537,288 | |||||||
| Total unrecognized compensation expense related to unvested common shares | $ 418,354 | ||||||||
| Accounts Payable [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Common shares per share | $ 0.04 | ||||||||
| Sale of common shares, shares | 151,456 | ||||||||
| Sale of common shares, value | $ 6,058 | ||||||||
| Warrants [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Warrant purchase, description | The Company issued a warrant to purchase up to 144,375 shares of the Company’s common stock (the “Warrant”). The Warrant is exercisable at any time on or after the date of the issuance and entitles this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrant, the holder is entitled to exercise the Warrant to purchase up to 144,375 shares of the Company’s common stock at an initial exercise price of $0.10, subject to adjustment as detailed in the Warrant. In connection with the issuance of the warrants, on the initial measurement date, the relative fair value of the warrants of $8,676 was recorded as a debt discount and an increase in paid-in capital (See Note 6). | ||||||||
| 2018 Long-term Incentive Plan [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Aggregate shares of common stock issued without any minimum vesting period | 25,000,000 | ||||||||
| Aggregate number of common stock issued under plan | 50,000,000 | ||||||||
| Incentive stock options | 11,445,698 | ||||||||
| Description of options to acquire common stock | The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company's common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company's outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date. | ||||||||
| Restricted stock have been issued | $ 15,250,000 | ||||||||
| Consulting Agreement [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Common shares per share | $ 0.04 | ||||||||
| Shares of grant restricted stock award of common shares | 1,250,000 | ||||||||
| Value of grant restricted stock award of common shares | $ 50,000 | ||||||||
| Stock-based professional fees | 8,334 | ||||||||
| Prepaid expenses | $ 41,666 | ||||||||
| Investor | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Common shares per share | $ 0.04 | $ 0.04 | |||||||
| Sale of common shares, shares | 7,000,000 | 7,000,000 | |||||||
| Sale of common shares, value | $ 280,000 | $ 280,000 | |||||||
| Series A Preferred Stock [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Shares designated | 800,000 | 800,000 | |||||||
| Preferred Stock par value | $ 0.10 | $ 0.10 | $ 0.10 | ||||||
| Preferred stock stated value | $ 0.10 | $ 1.00 | |||||||
| Preferred Stock dividend Rate | 4.00% | ||||||||
| Preferred stock dividend increased | 22.00% | ||||||||
| Conversion price converted into market price | 81.00% | ||||||||
| Market price representing at discount rate | 19.00% | ||||||||
| Debt premium charge to interest expenses | $ 30,449 | ||||||||
| Preferred stock unregistered | 159,600 | 159,600 | 103,200 | ||||||
| Cash proceeds | $ 127,000 | $ 127,000 | $ 80,000 | ||||||
| Net of fees | 6,000 | 6,000 | 6,000 | ||||||
| Amortization of Debt Discount | 6,000 | $ 6,000 | 6,000 | ||||||
| Amortization of discount charged to interest expense | 5,583 | 5,583 | |||||||
| Accrued interest | $ 3,153 | 3,153 | |||||||
| Common shares per share | $ 0.833 | $ 0.833 | |||||||
| Series A preferred stock balance | 306,016 | ||||||||
| Liquidation value | 262,800 | ||||||||
| Aggregate premium | 61,646 | ||||||||
| Unaccreted debt discount | 15,833 | ||||||||
| Unamortized debt offering costs | 5,750 | ||||||||
| Interest expense | $ 66,218 | ||||||||
| Series B Preferred Stock [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Shares designated | 100,000 | 100,000 | 100,000 | ||||||
| Preferred Stock par value | $ 0.10 | $ 0.10 | $ 0.10 | ||||||
| Preferred Stock dividend Rate | 2.00% | ||||||||
| Stated value | $ 1,000 | ||||||||
| Accrued Dividends | $ 108,000 | $ 657 | |||||||
| Liquidation value | 108,000 | ||||||||
| Conversion of principal balance | $ 108,657 | ||||||||
| Stock option, description | The Series B is convertible at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the "Conversion Price"). | ||||||||
| Convertible Preferred Stock [Member] | |||||||||
| Shareholders' Deficit (Textual) | |||||||||
| Settlement of accrued compensation | 108 | ||||||||